Cornerstone Wealth Group LLC Acquires 1,599 Shares of Colgate-Palmolive (NYSE:CL)

Cornerstone Wealth Group LLC lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 4.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 41,970 shares of the company’s stock after buying an additional 1,599 shares during the quarter. Cornerstone Wealth Group LLC’s holdings in Colgate-Palmolive were worth $3,816,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. D Orazio & Associates Inc. increased its stake in Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after purchasing an additional 108 shares in the last quarter. Fiducient Advisors LLC grew its stake in shares of Colgate-Palmolive by 5.2% in the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after buying an additional 110 shares during the period. Sequoia Financial Advisors LLC increased its position in Colgate-Palmolive by 0.6% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after buying an additional 113 shares in the last quarter. Great Waters Wealth Management raised its stake in Colgate-Palmolive by 1.5% during the 3rd quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock worth $796,000 after buying an additional 117 shares during the period. Finally, Waldron Private Wealth LLC boosted its holdings in Colgate-Palmolive by 2.1% in the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock worth $585,000 after acquiring an additional 118 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $87.88 on Monday. The firm has a market cap of $71.79 billion, a price-to-earnings ratio of 25.18, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The stock has a fifty day simple moving average of $91.81 and a two-hundred day simple moving average of $97.45. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1-year low of $80.03 and a 1-year high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of several research reports. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Stifel Nicolaus cut their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. Finally, UBS Group lowered their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.